Trial
NCT06162663
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical University of South Carolina
Collaborators
Merck Sharp & Dohme LLC
Condition
Breast Cancer
Intervention
Suvorexant Tablets
Why stopped
Failure to reach study enrollment milestones
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-27